PAS-004 in Patients With Advanced Solid Tumors

Clinical trial NCT06299839 · RECRUITING

Trial details

NCT number: NCT06299839
Sponsor: Pasithea Therapeutics Corp.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

RAS Mutation NF1 Mutation RAF Mutation Advanced Solid Tumors

Start date: 2024-02-29
Primary completion: 2026-02-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.